Corpus overview


MeSH Disease

HGNC Genes

There are no HGNC terms in the subcorpus



There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page

    Coincidence of COVID-19 MESHD epidemic and olfactory dysfunction MESHD outbreak

    Authors: Seyed Hamid Reza Bagheri; Ali Mohammad Asghari; Mohammad Farhadi; Ahmad Reza Shamshiri; Ali Kabir; Seyed Kamran Kamrava; Maryam Jalessi; Alireza Mohebbi; Rafieh Alizadeh; Ali Asghar Honarmand; Babak Ghalehbaghi; Alireza Salimi

    doi:10.1101/2020.03.23.20041889 Date: 2020-03-27 Source: medRxiv

    Background Recent surge of olfactory dysfunction MESHD in patients who were referred to ENT clinics and concurrent COVID-19 MESHDepidemic in Iran motivated us to evaluate anosmic/hyposmic patients to find any relation between these two events. Methods This is a cross-sectional study with an online checklist on voluntary cases in all provinces of Iran between the 12th and 17th March, 2020. Cases was defined as self-reported anosmia HP anosmia MESHD/ hyposmia HP in responders fewer than 4 weeks later (from start the of COVID-19 MESHD epidemic in Iran). Variables consist of clinical presentations, related past medical history, family history of recent respiratory tract infection HP respiratory tract infection MESHD and hospitalization. Results In this study 10069 participants aged TRANS 32.5 +/- 8.6 (7-78) years, 71.13% female TRANS and 81.68% non-smoker completed online checklist. They reported 10.55% a history of a trip out of home town and 1.1% hospitalization due to respiratory problems recently. From family members TRANS 12.17% had a history of severe respiratory disease MESHD in recent days and 48.23% had anosmia HP anosmia MESHD/ hyposmia HP. Correlation between the number of olfactory disorder MESHD and reported COVID-19 MESHD patients in all 31 provinces till 16th March 2020 was highly significant (Spearman correlation coefficient=0.87, p-Value<0.001). The onset of anosmia MESHD anosmia HP was sudden in 76.24% and till the time of filling the questionnaire in 60.90% of patients decreased sense of smell was constant. Also 83.38 of this patients had decreased taste sensation MESHD decreased taste sensation HP in association with anosmia MESHD anosmia HP. Conclusions It seems that we have a surge in outbreak of olfactory dysfunction MESHD happened in Iran during the COVID-19 MESHD epidemic. The exact mechanism of anosmia/hyposmia MESHD anosmia/hyposmia HP hyposmia HP in COVID-19 MESHD patients needs further investigations.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
HGNC Genes

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.